LGALS3 and obesity disorder: Notably, in obesity-related AMI models, Gal-3 synergizes with metabolic stressors (e.g., lipotoxicity) to amplify ER stress, leading to severe cardiomyocyte loss and fibrosis (Jimenez-Gonzalez et al., 2024).